Zobrazeno 1 - 10
of 1 112
pro vyhledávání: '"Duprez, E."'
Publikováno v:
In BioSystems September 2023 231
Publikováno v:
Journal of Economic Literature, 1972 Jun 01. 10(2), 484-486.
Externí odkaz:
https://www.jstor.org/stable/2721485
Autor:
Lecomber, R.
Publikováno v:
The Economic Journal, 1971 Jun 01. 81(322), 385-387.
Externí odkaz:
https://www.jstor.org/stable/2230089
Autor:
Tewes, Torsten
Publikováno v:
Weltwirtschaftliches Archiv, 1974 Jan 01. 110, 10-11.
Externí odkaz:
https://www.jstor.org/stable/40438786
Autor:
You Y; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Dunst J; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Ye K; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Sandoz PA; Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden., Reinhardt A; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Sandrock I; Institute of Immunology, Hannover Medical School, Hannover, Germany., Comet NR; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Sarkar RD; Max Planck Research Group, Würzburg Institute of Systems Immunology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany., Yang E; Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA, USA., Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis Lab, CRCM, CNRS, INSERM, Institut Paoli Calmettes, Aix Marseille University, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Agudo J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Brown BD; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Utz PJ; Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA., Kastenmüller W; Max Planck Research Group, Würzburg Institute of Systems Immunology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany., Gerlach C; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Prinz I; Institute of Immunology, Hannover Medical School, Hannover, Germany.; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute of Systems Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Önfelt B; Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Kreslavsky T; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. taras.kreslavskiy@ki.se.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. taras.kreslavskiy@ki.se.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Aug; Vol. 25 (8), pp. 1367-1382. Date of Electronic Publication: 2024 Jul 11.
Autor:
Garciaz S; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Berton G; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Hospital MA; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Guille A; Predictive Oncology Laboratory, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Adélaïde J; Predictive Oncology Laboratory, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Saillard C; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Hicheri Y; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Mozziconacci MJ; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Récher C; Department of Hematology, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.; Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France., Alary AS; Department of Cancer Biology, Institut Paoli-Calmettes, Marseille, France., Birnbaum D; Predictive Oncology Laboratory, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France., Vey N; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 May; Vol. 65 (5), pp. 700-703. Date of Electronic Publication: 2024 Feb 08.
Autor:
Ruchaud, S., Duprez, E., Gendron, M. C., Houge, G., Genieser, H. G., Jastorff, B., doskeland, S. O., Lanotte, M.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1994 Aug . 91(18), 8428-8432.
Externí odkaz:
https://www.jstor.org/stable/2365406
Autor:
Poplineau M; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Equipe Labellisée Ligue Nationale Contre le Cancer., Platet N; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Mazuel A; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Hérault L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer.; MABioS, I2M, Aix Marseille University,CNRS UMR7373, Marseille, France., N'Guyen L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Koide S; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Nakajima-Takagi Y; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Kuribayashi W; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Carbuccia N; Predictive Oncology Laboratory, CRCM, Aix Marseille University, CNRS UMR7258, INSERM 1068, Institut Paoli-Calmettes, Marseille, France., Haboub L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Vernerey J; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France., Oshima M; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Birnbaum D; Predictive Oncology Laboratory, CRCM, Aix Marseille University, CNRS UMR7258, INSERM 1068, Institut Paoli-Calmettes, Marseille, France., Iwama A; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Duprez E; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer.
Publikováno v:
Blood [Blood] 2022 Dec 01; Vol. 140 (22), pp. 2358-2370.
Autor:
Hérault L; Aix Marseille Université, CNRS, Marseille I2M, France.; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Poplineau M; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis Team, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Remy É; Aix Marseille Université, CNRS, Marseille I2M, France.
Publikováno v:
Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2022 Nov 02; Vol. 21, pp. 21-33. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2023).